Trial
NCT07196111
BAFFR CAR-T Treatment for Relapsed/Refractory B-cell Tumors
Early Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Guangzhou Bio-gene Technology Co., Ltd
Collaborators
—
Condition
B Acute Lymphoblastic Leukemia/Lymphoma
Intervention
BAFFR CAR-T
Why stopped
Due to corporate strategic adjustment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-28